Related Experiment Videos
Hepatolithiasis associated with cholangiocarcinoma
1Department of Surgery, Veterans General Hospital Taipei, National Yang Ming University, Shihpai, Taiwan, Republic of China.
The British Journal of Surgery
|July 1, 1997
Summary
Hepatolithiasis (intrahepatic stones) complicates cholangiocarcinoma diagnosis and treatment, leading to poorer survival rates. Early detection and intervention are crucial for improving outcomes in these complex cases.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Intrahepatic stones (hepatolithiasis) are prevalent in East Asia.
- Hepatolithiasis is a known risk factor for cholangiocarcinoma.
- Accurate pre-operative diagnosis of coexistent hepatolithiasis and cholangiocarcinoma is challenging.
Purpose of the Study:
- To investigate the impact of intrahepatic stones on the diagnosis, treatment, and survival of patients with cholangiocarcinoma.
- To compare outcomes between patients with hepatolithiasis and cholangiocarcinoma versus those with intrahepatic cholangiocarcinoma alone.
Main Methods:
- Retrospective analysis of 33 patients with hepatolithiasis and cholangiocarcinoma (1981-1994).
- Comparison with 18 patients with intrahepatic cholangiocarcinoma without stones.
- Evaluation of diagnostic rates, treatment choices, and survival data.
Main Results:
- Patients with stones presented with longer symptom duration and more prior biliary surgeries.
- Preoperative diagnosis rates were lower in patients with hepatolithiasis.
- Significantly inferior 5-year survival rates were observed in patients with hepatolithiasis (2/32 vs. 4/14 overall; 2/17 vs. 4/9 resectable cases).
Conclusions:
- Survival disparities in stone-containing cholangiocarcinoma are linked to delayed diagnosis and fewer curative resections.
- Hepatolithiasis poses significant challenges in managing cholangiocarcinoma.
- Further research into optimizing diagnosis and treatment strategies for this patient group is warranted.